10 Female subjects of childbearing potential must have a negative serum human chorionic gonadotropin -hCG at Visit 1 and a negative urine pregnancy test prior to randomization at Visit 2 Female subjects of period of at least 60 days following administration of the last dose of study medication to commit to the consistent and correct use of a medically acceptable method of birth control e.g. a double-barrier method condom spermicide condom diaphragm with spermicide Abstinence will be considered an acceptable method of contraception on a case by case basis upon prior approval by the Medical Monitor 